HAMBURG, Germany - Thursday, January 21st 2016 [ME NewsWire]
(BUSINESS WIRE)-- PENTAX Europe GmbH has acquired the remaining stock of PENTAX Italia S.r.L. from Movi S.p.A. This further investment by PENTAX Europe GmbH into the Italian healthcare market strengthens PENTAX Medical’s position in Italy and will bring enhanced customer and professional education services to its Italian customers.
Established in 2007, PENTAX Italia was co-owned by PENTAX Europe GmbH and Movi S.p.A., an Italian distributor of healthcare products. PENTAX Italia has increased its sales of endoscopy products and services over this time, leading to PENTAX Europe GmbH’s decision to acquire full ownership.
Commenting on the acquisition, Rainer Burkard, Managing Director PENTAX Europe GmbH and President PENTAX Medical EMEA said: “Italy has been a strong market for PENTAX Medical and we are keen to continue our growth and bring our market leading products and services to as many customers in Italy as possible. To that end I am really pleased that PENTAX Italia will now be a wholly-owned subsidiary of PENTAX Medical, and thank Movi for its support and contribution to PENTAX Italia’s development.”
Adriano Tinelli, Managing Director PENTAX Italia S.r.L. said: “PENTAX Italia’s success has been built on a combination of both our innovative, high-performance endoscopy products and, importantly, our customer focus. We are very excited about how we can develop our customer experience and we look forward to strengthening our ability to bring our products and professional education services to clinicians throughout Italy.”
Enrico Piero Bassani, president of Movi S.p.A, commented: “PENTAX Italia has been a successful company for many years, thanks to the strong commitment of both shareholders that worked very positively together. The acquisition of our minority share by PENTAX Europe GmbH was a natural step for us and of course we wish PENTAX Italia to continue its development, to increase the market share, and keep a strong position in our important market.”
Details of the deal were not disclosed.
About PENTAX Medical
PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe.
For more information, please visit: www.pentaxmedical.com.
Contacts
Company enquiries
PENTAX Europe GmbH
Katharina Meitzler, Marketing Communications EMEA
t: +49 40 561920
e: katharina.meitzler@pentaxmedical.com
w: www.pentaxmedical.com
or
Media enquiries
Alto Marketing Limited
Andrew Fellows, Client Account Director - Healthcare
t: +44 (0)1489 557672
e: andrewf@alto-marketing.com
w: www.alto-marketing.com
Permalink: http://me-newswire.net/news/16847/en
(BUSINESS WIRE)-- PENTAX Europe GmbH has acquired the remaining stock of PENTAX Italia S.r.L. from Movi S.p.A. This further investment by PENTAX Europe GmbH into the Italian healthcare market strengthens PENTAX Medical’s position in Italy and will bring enhanced customer and professional education services to its Italian customers.
Established in 2007, PENTAX Italia was co-owned by PENTAX Europe GmbH and Movi S.p.A., an Italian distributor of healthcare products. PENTAX Italia has increased its sales of endoscopy products and services over this time, leading to PENTAX Europe GmbH’s decision to acquire full ownership.
Commenting on the acquisition, Rainer Burkard, Managing Director PENTAX Europe GmbH and President PENTAX Medical EMEA said: “Italy has been a strong market for PENTAX Medical and we are keen to continue our growth and bring our market leading products and services to as many customers in Italy as possible. To that end I am really pleased that PENTAX Italia will now be a wholly-owned subsidiary of PENTAX Medical, and thank Movi for its support and contribution to PENTAX Italia’s development.”
Adriano Tinelli, Managing Director PENTAX Italia S.r.L. said: “PENTAX Italia’s success has been built on a combination of both our innovative, high-performance endoscopy products and, importantly, our customer focus. We are very excited about how we can develop our customer experience and we look forward to strengthening our ability to bring our products and professional education services to clinicians throughout Italy.”
Enrico Piero Bassani, president of Movi S.p.A, commented: “PENTAX Italia has been a successful company for many years, thanks to the strong commitment of both shareholders that worked very positively together. The acquisition of our minority share by PENTAX Europe GmbH was a natural step for us and of course we wish PENTAX Italia to continue its development, to increase the market share, and keep a strong position in our important market.”
Details of the deal were not disclosed.
About PENTAX Medical
PENTAX Medical is a division of HOYA Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe.
For more information, please visit: www.pentaxmedical.com.
Contacts
Company enquiries
PENTAX Europe GmbH
Katharina Meitzler, Marketing Communications EMEA
t: +49 40 561920
e: katharina.meitzler@pentaxmedical.com
w: www.pentaxmedical.com
or
Media enquiries
Alto Marketing Limited
Andrew Fellows, Client Account Director - Healthcare
t: +44 (0)1489 557672
e: andrewf@alto-marketing.com
w: www.alto-marketing.com
Permalink: http://me-newswire.net/news/16847/en